
  
    
      
        
        There_RB are_VBP at_IN least_JJS 300_CD million_CD acute_JJ cases_NNS of_IN malaria_NN each_DT year_NN globally_RB ,_, resulting_VBG in_IN
        more_JJR than_IN a_DT million_CD deaths_NNS ._. Ninety_CD percent_NN of_IN deaths_NNS due_JJ to_TO malaria_NN occur_VB in_IN Africa_NNP south_RB
        of_IN the_DT Sahara_NNP ,_, and_CC most_JJS occur_VB in_IN young_JJ children_NNS ._. Of_IN the_DT four_CD types_NNS of_IN human_JJ malaria—_NN
        Plasmodium_NNP vivax_NN ,_, 
        P_NN ._. malariae_NN ,_, 
        P_NN ._. ovale_NN ,_, and_CC 
        P_NN ._. falciparum_NN —_NN
        P_NN ._. falciparum_NN malaria_NN is_VBZ most_RBS common_JJ in_IN Africa_NNP ,_, and_CC it_PRP accounts_VBZ
        for_IN most_JJS of_IN the_DT extremely_RB high_JJ mortality_NN south_RB of_IN the_DT Sahara_NNP ._.
        Malaria_NNP parasites_NNS are_VBP developing_VBG unacceptable_JJ levels_NNS of_IN drug_NN resistance_NN ,_, and_CC many_JJ
        insecticides_NNS are_VBP no_DT longer_RB useful_JJ against_IN mosquitoes_NNS transmitting_VBG the_DT disease_NN ._. Vaccine_NNP
        research_NN has_VBZ produced_VBN few_JJ hopeful_JJ candidates_NNS ,_, and_CC although_IN millions_NNS of_IN dollars_NNS are_VBP poured_VBN
        into_IN research_NN ,_, an_DT effective_JJ vaccine_NN is_VBZ years_NNS away_RB ._.
        One_CD recurring_VBG theme_NN in_IN malaria_NN vaccine_NN research_NN has_VBZ been_VBN the_DT high_JJ frequency_NN of_IN the_DT gene_NN
        for_IN sickle_NN cell_NN hemoglobin_NN (_( HbS_NNP )_) in_IN malaria_NN endemic_JJ regions_NNS ,_, which_WDT is_VBZ believed_VBN to_TO be_VB due_JJ to_TO
        a_DT heterozygote_NN (_( HbAS_NNP )_) advantage_NN against_IN fatal_JJ malaria_NN ._. The_DT mechanism_NN behind_IN the_DT high_JJ degree_NN
        of_IN resistance_NN conferred_VBD by_IN HbAS_NNP in_IN severe_JJ and_CC complicated_VBN malaria_NN is_VBZ still_RB unknown_JJ ,_, but_CC
        recent_JJ observations_NNS have_VBP suggested_VBN the_DT mechanism_NN might_MD involve_VB an_DT immune_JJ component_NN ._.
        In_IN this_DT month_NN 's_POS 
        PLoS_NNP Medicine_NNP ,_, Thomas_NNP Williams_NNP and_CC colleagues_NNS reason_VBP that_IN the_DT best_JJS way_NN
        to_TO test_VB whether_IN malaria_NN protection_NN by_IN HbAS_NNP has_VBZ a_DT significant_JJ immune_JJ component_NN is_VBZ to_TO see_VB
        whether_IN protection_NN varies_VBZ with_IN age_NN ._. They_PRP studied_VBD the_DT age-specific_JJ malaria_NN pattern_NN in_IN 1_CD ,_, 054_CD
        children_NNS and_CC adults_NNS living_VBG in_IN Kilifi_NNP District_NNP on_IN the_DT coast_NN of_IN Kenya_NNP ._. They_PRP argued_VBD that_IN if_IN
        the_DT malaria_NN protection_NN provided_VBN by_IN HbAS_NNP were_VBD innate_JJ ,_, it_PRP should_MD be_VB independent_JJ of_IN malaria_NN
        exposure_NN and_CC remain_VB constant_JJ with_IN age_NN ._. However_RB ,_, if_IN immune_JJ mechanisms_NNS were_VBD involved_VBN ,_,
        protection_NN should_MD increase_VB with_IN age_NN until_IN children_NNS become_VBP functionally_RB immune_JJ ,_, when_WRB
        additional_JJ immunological_JJ advantage_NN should_MD be_VB lost_VBN ._.
        They_PRP found_VBD that_IN overall_JJ HbAS_NNP was_VBD nearly_RB 40_CD %_NN protective_JJ against_IN mild_JJ clinical_JJ malaria_NN ._.
        Protection_NNP varied_VBD with_IN age_NN ,_, increasing_VBG from_IN 20_CD %_NN to_TO 60_CD %_NN during_IN the_DT first_JJ ten_CD years_NNS of_IN life_NN ,_,
        and_CC thereafter_RB returning_VBG to_TO 30_CD %_NN in_IN children_NNS more_JJR than_IN ten_CD years_NNS old_JJ ._.
        The_DT authors_NNS admit_VBP that_IN this_DT observation_NN could_MD be_VB due_JJ to_TO any_DT factor_NN that_WDT affects_VBZ malaria_NN
        risk_NN and_CC varies_VBZ with_IN age_NN but_CC state_NN that_WDT accelerated_VBD immune_JJ acquisition_NN seems_VBZ the_DT most_RBS
        likely_JJ explanation_NN ._. They_PRP suggest_VBP several_JJ mechanisms_NNS for_IN how_WRB HbAS_NNP could_MD accelerate_VB immune_JJ
        acquisition_NN ;_: for_IN example_NN ,_, immunity_NN could_MD be_VB mediated_JJ by_IN accelerated_JJ acquisition_NN of_IN
        antibodies_NNS to_TO altered_VBN host_NN antigens_NNS expressed_VBD on_IN the_DT parasite-infected_JJ red_JJ cell_NN
        surface_NN ._.
        In_IN discussing_VBG their_PRP$ findings_NNS the_DT authors_NNS point_VBP out_IN that_IN their_PRP$ study_NN focused_VBN on_IN mild_JJ
        malaria_NN ._. For_IN accelerated_VBD malaria-specific_JJ immunity_NN to_TO be_VB relevant_JJ to_TO HbAS_NNP selection_NN it_PRP
        would_MD have_VB to_TO operate_VB within_IN a_DT period_NN of_IN maximum_NN risk_NN for_IN severe_JJ and_CC fatal_JJ malaria_NN ._. They_PRP
        note_VBP that_IN in_IN a_DT recent_JJ study_NN ,_, conducted_VBN by_IN another_DT group_NN in_IN western_JJ Kenya_NNP ,_, protection_NN
        against_IN severe_JJ malaria_NN by_IN HbAS_NNP was_VBD only_RB seen_VBN in_IN children_NNS 2_CD –_NN 16_CD months_NNS old_JJ ,_, but_CC that_IN in_IN that_DT
        study_NN ,_, no_DT analysis_NN was_VBD presented_VBN that_WDT addressed_VBD the_DT effect_NN of_IN age_NN within_IN that_DT range_NN ._.
        The_DT authors_NNS conclude_VBP that_IN the_DT relevance_NN of_IN their_PRP$ current_JJ observations_NNS on_IN mild_JJ clinical_JJ
        malaria_NN to_TO protection_NN against_IN severe_JJ and_CC fatal_JJ malaria_NN are_VBP unknown_JJ ,_, and_CC that_IN further_JJ work_NN
        must_MD be_VB done_VBN to_TO better_RB understand_VB the_DT role_NN of_IN HbAS_NNP in_IN protection_NN against_IN malaria_NN ._.
      
    
  
